13 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2244405/gsk-follows-rivals-to-cap-out-of-pocket-inhaler-cost-in-us?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2244405
Mar 21, 2024 - GSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month in the United States. The company intends to start this in 2025.
zc:-5021796422199526666
0
https://www.zacks.com/stock/news/2244375/industrial-precision-unit-aids-nordson-ndsn-despite-cost-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2244375
Mar 21, 2024 - Nordson (NDSN) is set to benefit from the solid momentum in the Industrial Precision segment and accretive acquisitions. However, high costs are concerning.
zc:6950900959938054964
0
https://www.zacks.com/stock/news/2244299/b-g-foods-bgs-innovation-pipeline-bodes-well-amid-high-costs?cid=CS-ZC-FT-analyst_blog|rank_focused-2244299
Mar 21, 2024 - B&G Foods (BGS) bolsters its product range with innovative seasoning blends and streamlines its portfolio for higher profitability despite facing challenges from increased SG&A expenses.
zc:4332061036771930526
0